Edwin A. Cohen

Prior to founding Summit, Mr. Cohen was the Founder, CEO and Chairman of Intranasal Therapeutics, Inc. and an original investor in ScinoPharm (Taiwan), after a successful career in the generic pharmaceutical industry. Most notably, he is founder and former Chairman and CEO of Barr Laboratories, Inc., a pharmaceutical company that traded on the NYSE and grew to over $3 billion in annual sales before its acquisition by Teva in 2008 for $7.5 billion. He also co-founded Davis Edwards Pharmacal Corporation, one of the first companies to manufacture and promote multisource drugs. He is a founding member of the Board of Directors of the Generic Pharmaceutical Industry Association, the predecessor to the Association for Accessible Medicines, and a founding member and Executive Board member of the National Association of Pharmaceutical Manufacturers. A graduate of Fordham University, Mr. Cohen received an Honorary Doctor of Science Degree and was appointed to the Board of Trustees of this institution.